Raymond James Maintains Outperform on Haemonetics, Raises Price Target to $88

Raymond James analyst Andrew Cooper maintains Haemonetics (NYSE:HAE) with a Outperform and raises the price target from $76 to $88.

Raymond James analyst Andrew Cooper maintains Haemonetics (NYSE:HAE) with a Outperform and raises the price target from $76 to $88.

Total
0
Shares
Related Posts